GlassScriptPhysician profile
Ruba Amad
NPI 1659627859
$5,853.67
in general payments reported to CMS, 2019-2025
25 companies · $1,617 in 2025
The $1,617 reported for 2025 was more than what 96% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $694 · 2020: $224 · 2021: $477 · 2022: $786 · 2023: $1,005 · 2024: $1,051 · 2025: $1,617.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,537 · Entertainment: $136.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,536.72 |
| Entertainment | $136.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,467.17 | 2019-2025 | Precision 1, Precision7, Total30 |
| Coopervision INC. | $846.45 | 2019-2025 | Myday Contact Lens, Clariti Contact Lens |
| Sun Pharmaceutical Industries INC. | $369.35 | 2021-2025 | Cequa |
| Optos, INC. | $292.42 | 2020-2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Carl Zeiss Meditec USA, INC. | $285.02 | 2023-2024 | Cirrus Hd-Oct |
| Lkc Technologies, INC. | $242.11 | 2024-2025 | |
| Sight Sciences, INC. | $235.49 | 2019-2023 | Tearcare System |
| Abbvie INC. | $230.99 | 2022-2024 | |
| Bausch & Lomb Americas INC. | $153.37 | 2023-2025 | Infuse |
| Apellis Pharmaceuticals, INC. | $146.17 | 2025 | |
| Glaukos Corporation | $125.11 | 2025 | Idosetr |
| Novartis Pharmaceuticals Corporation | $125.00 | 2020 | |
| Johnson & Johnson Vision Care, INC. | $124.81 | 2024 | Acuvue |
| Alexion Pharmaceuticals, INC. | $121.86 | 2025 | Ultomiris |
| Astellas Pharma US INC | $121.86 | 2025 | Izervay |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $119.93 | 2024 | |
| Dompe US, INC. | $116.74 | 2024 | Oxervate |
| Abb Con-Cise Optical Group LLC | $114.15 | 2023 | Spectacle Lenses, Contact Lens |
| Synergeyes, INC. | $111.92 | 2019-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $108.99 | 2019 | |
| Rxsight INC | $105.62 | 2022 | |
| Quidel Corporation | $97.55 | 2019 | |
| Aerie Pharmaceuticals, INC. | $90.68 | 2019 | |
| Maculogix, INC. | $72.91 | 2021 | |
| Shire North American Group INC | $28.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ruba Amad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.